Rep. Sara Jacobs’ Statement on Federal Court Ruling That Could Suspend FDA’s Approval of Mifepristone
Washington, April 7, 2023 | Lauren McIlvaine
Following a federal court ruling today that could suspend the Food and Drug Administration’s decades-long approval of mifepristone and block 40 million women from abortion access, Congresswoman Sara Jacobs (CA-51) released the following statement:
“As a 34-year-old woman, I can’t take this anymore – another massive, misogynistic attack on my health care by a man who doesn’t know a damn thing about my body. This unilateral decision has far-reaching, life-altering consequences: it could strip 40 million more people of their dignity and their right to access health care. It furthers Republicans’ ultimate dream of banning abortion across the country by mainly targeting people living in blue states. And it could overly burden already overwhelmed clinics, worsen the maternal mortality crisis, and endanger patients facing ectopic pregnancies, miscarriages, and other conditions.
“This has nothing to do with patient care – mifepristone is safer than Tylenol and has been approved by the FDA for two decades. But yet again, radical Republicans are intervening where they don’t belong in personal and private health care decisions. I’m urging the FDA to use its authority to keep abortion pills available to Americans who need them. I will keep fighting against this shameful decision and toward building a society where all reproductive health care options, including abortion, aren’t only legal, but affordable, accessible, and stigma-free.”